| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (2MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-778398
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.77839
Zusammenfassung
The majority of phase III clinical trials use a 2-arm randomized controlled trial with 50% allocation between the control treatment and experimental treatment. The sample size calculated for these clinical trials normally guarantee a power of at least 80% for a certain Type I error, usually 5%. However, these sample size calculations, do not typically take into account the total patient ...

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

Downloadstatistik